Navigation Links
Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
Date:8/19/2007

epted by the market, including the risk that these products will not be competitive with products offered by other companies; and (2) other factors that might be described from time to time in Applera's filings with the Securities and Exchange Commission. All information in this press release is as of the date of the release, and Applera does not undertake any duty to update this information, including any forward-looking statements, unless required by law.

About Abbott's Molecular Diagnostics Business

Abbott Molecular, a division of Abbott based in Des Plaines, Ill., is an emerging leader in molecular diagnostics -- the analysis of DNA, RNA and proteins at the molecular level. Abbott Molecular's instruments and tests provide physicians with critical information based on the early detection of pathogens and subtle, but key changes in patients' genes and chromosomes. They help physicians diagnose disease and infections earlier, select appropriate therapies and monitor disease progression. In addition to the RealTime HIV-1 viral load test and the Abbott m2000, Abbott Molecular's portfolio of products also includes innovative genomic tests for chromosome changes associated with congenital disorders and cancer, including the PathVysion(R) HER-2 DNA Probe Kit, a test used to help select women with breast cancer who could benefit from Herceptin(R) therapy, and UroVysion(TM), which detects genetic changes in bladder cells for aiding in the diagnosis of bladder cancer in patients with hematuria (blood in the urine) and for monitoring bladder cancer recurrence.

About Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs 65,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available at the company's Web site
'/>"/>

SOURCE Abbott

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5 6

Related medicine technology :

1. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
2. Abbott Announces Positive Nine-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
3. Abbott Announces Continued Positive Results with Xience V Everolimus Eluting Coronary Stent in Spirit Clinical Trials
4. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease
5. Abbotts Investigational Treatment ABT-874 Shows Positive Results in Phase II Psoriasis Study
6. Abbott Researchers Focus on New Cutting-Edge Approaches in the Fight Against Cancer
7. Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and Effective Treatment to Reduce Risk of Stroke
8. Abbott Announces Positive Six-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent
9. Abbotts Xience V Everolimus Eluting Coronary Stent Superior to Taxus Stent in Spirit III U.S. Pivotal Clinical Trial
10. Abbott to Present New Data Across its Vascular Portfolio at the American College of Cardiologys 56th Annual Scientific Session
11. Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic Drug to Treat Viral Eye Infection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... Mass. , May 29, 2015  Haemonetics Corporation ... Davies , Chief Operating Officer, will present at the ... York on June 23 rd , 2015 ... may access Mr. Davies, presentation live via webcast at: ... Haemonetics (NYSE: HAE ) is a global healthcare ...
(Date:5/29/2015)... , May 29, 2015  Eli Lilly and Company ... ) today announced that they have entered into a ... efficacy of AstraZeneca,s investigational anti-PD-L1 immune checkpoint inhibitor, MEDI4736, ... Receptor 2 antiangiogenic cancer medicine. The planned study will ... advanced solid tumors. The Phase I study ...
(Date:5/29/2015)... Pa. , May 29, 2015 ... focus of the Association for the Advancement of ... With support from AAWC,s corporate partners, ... Educational Portal on the AAWC website at ... a wound care pathway with links to various ...
Breaking Medicine Technology:Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 2Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 3Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 4Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 5Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 6Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 7Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 8Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 9Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 10Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 11Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 12Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 13Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 14The Association for the Advancement of Wound Care Educates the Public 2
(Date:5/29/2015)... 2015 Health DataPalooza is a national ... discuss and foster the most effective and innovative ways ... Conference is hosted by the Health Data Consortium, which ... to promote and develop the use of open healthcare ... groups to narrow in on how to actually put ...
(Date:5/29/2015)... May 29, 2015 External Counterpulsation, also known ... disease treatment for patients. The Heart Fit Clinic is the ... released a raving review from patients who are now completing ... and underwent 35 treatments of ECP treatment and received great ... here. Not only does the clinic perform this non-surgical treatment ...
(Date:5/29/2015)... 2015 News: 2015-2016 Oil Market Forecast, ... http://www.carsonenergy.com , In July, 2014, the ... the boom in US shale production and increased production ... regain market share from US shale producers, started producing ... more oil out into the marketplace, they could push ...
(Date:5/29/2015)... 2015 The world of dentistry had an ... dentists as sadists who dispense pain to people unfortunate enough ... more, when it came to surgeries, people would have to ... but that's all back in the 20th Century now. Nowadays ... in the Sheepshead Bay neighborhood of Brooklyn, New ...
(Date:5/29/2015)... Testosterone Centers of Texas (TCT), one of the leading testosterone ... in the Mid-Cities area to serve Hurst, Colleyville, North Richland ... the south side of Hwy 26, one block west of ... open in May and will offer comprehensive testosterone therapy for ... TCT’s other testosterone clinics, this clinic will also offer ancillary ...
Breaking Medicine News(10 mins):Health News:RowdMap, Inc. Speaks on Government Health Data and Applications for Transparency, No Value Care, and Pay-for-Value Risk Arrangements at Health Datapalooza 2Health News:RowdMap, Inc. Speaks on Government Health Data and Applications for Transparency, No Value Care, and Pay-for-Value Risk Arrangements at Health Datapalooza 3Health News:External Counterpulsation at Heart Fit Clinic Receives Raving Review 2Health News:Breaking News: Carson Energy Releases 2015-2016 Oil Forecast 2Health News:Brooklyn Dentist Delivers Comfortable Care Through High Technology 2Health News:Brooklyn Dentist Delivers Comfortable Care Through High Technology 3Health News:Brooklyn Dentist Delivers Comfortable Care Through High Technology 4Health News:Testosterone Clinics in Colleyville — TCT opens Hurst Location 2Health News:Testosterone Clinics in Colleyville — TCT opens Hurst Location 3
... Institute of Medicine recommends ways to avert an impending health care ... number of health care workers with the skills to meet their ... older by 2030 as the baby boom generation ages. The ... do to ensure that older Americans get the best care possible. ...
... 11 /Xinhua-PRNewswire-FirstCall/ -- Linkwell,Corporation (Linkwell) (OTC Bulletin ... of healthcare related disinfectants in China,announced today ... Hi-Tech Company, Ltd., (LiKang Disinfectant) was selected ... Ministry of Human Resources and,Social Security (MOHRSS) ...
... to evaluate palpable breast lesions, they can rule out ... conducted by researchers at Baystate Health in Springfield, MA. ... protocol. , We were interested in finding out ... together, in excluding breast cancer in women with palpable ...
... Registration is now,open for CleanMed 2008, ... practices and green building. The event is,produced ... Harm,along with partners Consorta, the Heinz Endowments, ... Center., CleanMed attracts major health care ...
... Set for June as Plan Moves Forward, HARRISBURG, ... provide input on Pennsylvania,s new State Plan on Aging., ... to help the,Department of Aging prioritize the needs and ... wellness and fitness programs, legal,assistance, and long-term living options. ...
... cancer patients who had an MRI examination before their initial ... out of Yale University School of Medicine. , ... treatment and 374 who did not undergo an MRI examination. ... Carol Lee, MD, an author of the study, now at ...
Cached Medicine News:Health News:Linkwell Corporation Selected to Train and License all Disinfectant and Pest Control Professionals in China and for the Beijing Olympics 2Health News:Linkwell Corporation Selected to Train and License all Disinfectant and Pest Control Professionals in China and for the Beijing Olympics 3Health News:Mammography plus sonography can help rule out breast cancer in patients with palpable lesions 2Health News:Creating Healing Environments: Healthcare Industry's Largest Sustainability Conference to be Held May 20-22 in Pittsburgh 2Health News:April 15 is Deadline for Input on State Aging Plan 2
... Rapid Toxin A Test gives your laboratory clear-cut ... it might be C. difficile, you can't afford ... a few tests a day or sends out ... Toxin A C. difficile Rapid Toxin A Test ...
... C. Diff A is a ... qualitative detection of Clostridium difficile ... , ,Clearview C. Diff A ... to provide fast, accurate detection ...
... come back with better resolution, accuracy and ... 25 or 31 rings (same as TMS-1), ... provides high accuracy & repeatability. The small ... & provides extensive corneal coverage. The low ...
... The OCULUS Pachycam is the first ... built-in keratometer. The OCULUS Pachycam ... (intra ocular pressure) in accordance with ... "real IOP. The OCULUS Pachycam ...
Medicine Products: